Member Info for LovableLumax

I do find it funny when creepy James tries to goad me. We'll see if he's so gobby in person. Phevs has consistently said nominee TR1s are worthless but now we finally have one showing buys and it suddenly matters. IMO it's positive and all the TR1s of reductions negative. We'll only know if buying now is wise once we have an RNS on funding which will surely arrive in the next coupe of weeks.

Given phevs accused the BOD of corruption in what he called the 'mates rates' raise I'm surprised he'd be allowed to show his deviant face.

As I said yesterday I have no idea which way this will go but I bet it's either boom or a very hard slog as billions more shares needed. Recent news suggests the former but we'll see.

* Mirriad raise RNS was 3 May last year and 16 May the year before

Mirriad was RNS was 3 May last year and 16 May the year before. Surely one is coming soon. What I will say is I suspect the raise will be received much better this year as surely the terms will be better as well as the commentary around it. Rembrand raised a chunk and also had a client (L’Oréal) take a stake. If mirriad is unable to do something similar and offer a discount with more jam tomorrow it’ll be a disaster. Recent news surely makes that a lot less likely. An interesting couple of weeks ahead for sure.

Avacta continues to enroll patients in three Phase 1b expansion cohorts in salivary gland cancer, triple negative breast cancer and high-grade soft tissue sarcoma with data anticipated by the end of 2025.

Sam what a pathetic drip. You obviously know the machinations of audits going concern more than me. Tell me where I’m wrong.

I’m always on time and he’s always late but beats me 9/10. Main thing is to play well.

As I say this could have come good and if so could move into the pennies and quickly. We’ll see what the next week or two brings

About to play tennis so will reply to any further comments later

FFS I don’t have their management accounts so don’t know Jan to now revenue (campaigns run and monies owed), whether they’ve got to £2m costs a Q or still on c£2.2m but I know H1 always a lot slower (H1 last year c£400k) and they only had £4.8m in cash and my guess is they will have less than £3m end of this month. Let’s say they have £3m end of this month it'll mean they've generated £1m revenue in 4 months (assuming £700k/month costs). That'll be very good. Unless they have signed orders the auditor will want cash to sign the accounts off. Really simple.

This is painful. If you can’t get your head around it I can’t dumb it down any more.

Apologies I meant LOTM.

Phevs are you slow or disingenuous. Mirriad has reduced its costs pa to £8m. If mirriad has £3m left in cash and no visibility on forward orders the auditor will very likely want a £5m cash injection, if they have £2m cash they will need £6m. Get it?!

As I said they may have good visibility on forward orders (signed not pipeline) but the auditor willl know mirriad has always missed its guidance so won’t take their word for it. It’s their job not to!

Anyway, what I say stands, mirriad could have turned a corner revenue wise and may only need a small raise and could be at 1p for all I know.

That said if they need £5m or £6m they’ll get shafted IMO. Obvs all the news points to the former. We should know within 2 weeks.

Pumping, ha, that’s a little rich.

You thought the company determined how much cash they need to have the accounts signed off when it’s the auditor.

Again last April mirriad guided £4m FY revenue, had £3.5m cash yet needed a minimum raise of £5.5m and it’s no coincidence £3.5m cash plus £5.5m raise makes their 12 month cost base which is what the auditor wanted. Their pie in the sky guidance was ignored and rightly so as they only hit £1m FY.

I got criticised for not posting on good days so here I am. This again looks positive but the proof is in the revenue uptick. Come the end of this month they surely have less than £3m cash (had £3.5m last time they raised) and they need audit signed off before end of June and 12 months cash or signed orders and cash amounting to 12 months costs. They can’t surely wait to see what upfronts yields sales-wise as leaving it so late has its own risks. My money is on a raise next week and an RNS on Friday at 5pm. If it’s not the following Friday then surely revenues and sales looking superb.

Dox is dox, Avacta has not tweaked the molecule at all so dumping a lot more dox into tumors sensitve to dox will be efficacious as data so far shows. The molecule will not suddenly change, it's very well understood. Avacta has gone after SGC as a no standard of care so the quickest way to approval and revenue. Strategy makes sense as well as going after a much more commercially attracitve target in TNBC. A good mix. Something has to give between now and audit sign off

ATH I doubt any holder would complain as shareholder value created. If the science as gold we we think and they say it should not be beyond their capabilities to place the converted shares. Anyway, news needed before audit sign off so perhaps we will finally get a deal. I’ll judge them on or before accounts signed off as something happening beforehand

Pander to impatient holders. They work for holders and part of the CEO’s job is to create sustainable shareholder value and 12 months in not a dicky. That could well change but calling people bed wetters pathetic when they’re legitimate concerns.

Icecool I expect you’ll have the same ridiculous narrative if we are at 1p. Fair criticism of the BoD isn’t bed wetting. You’re either deluded or in denial. The science looks super but the commercial savvy looks wanting as it did with the previous BoD. Hopefully AACR offers a reprieve from the falling share price and quickly followed by a cash influx which is needed for audit sign off next month. Hopefully good news en route but who knows.

Did you guys see when mirriad did channel 4 VPP and it was pretty awful?! Think it was Location location location and before and after ad breaks they had to say we have product placement so I doubt itv is doing much if anything.

I really hope strategic investors are found which given rembrand shouldn’t be hard but who knows. Awful raising money at the mo, especially on AiM.

conversion circa 32p, **** poor from bod but not surprising. they’ll need some solid news before the agm and july’s conversion.

Hi bullish, I hold 500k shares from many years ago at a high average although I have clawed some of my paper losses back. I post on here as a counter to the uber rampers who just 12 months ago were apologising to readers on this BB and others as they sold the story without realising a raise was en route. Anyway, let's not go over old ground. I won't invest any more cash here or in any AIM listed PLCs as I think it's a basket case. I have one other holding on AIM and the others are MAIN or funds.

Anyone who agrees with LOTM and think Mirriad will decide how much cash it needs on its balance sheet to have their accounts signed off is in fantasy land. Anyway, we'll see if all the LinkedIn posts have meant a significant uptick in revenues or not, in the past they haven't. Of course that may have changed. It's an awful time to raise cash from a macro POV but if MIRI has nailed programmatic and has agencies committing to spend X $m with them in a defined period they could do very well indeed but if it's more jam tomorrow it'll be painful.

I'm not sure my posts rile some, as nothing is pie in the sky. Anyway, we should know the state of play soon enough and IMO it's 50/50 which way it goes.